BUZZ-Street View: Thermo's solid quarter signals easing demand weakness ** Thermo Fisher TMO.N raised its annual profit outlook on Wednesday and posted a better-than-expected profit in the second quarter, banking on improved demand for its tools and services used in clinical trials. SOLID QUARTER BY TMO SIGNALS RECOVERY ** RBC Capital Markets ("out

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Lamb Weston, Blackstone Mortgage Trust Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq plummeted to a one-month low on Wednesday after Tesla and Alphabet disappointed with lackluster earnings, prompting investors to question if the Big Tech and AI-fueled 2024 equity rally was sustainable in the long run.

BUZZ-U.S. STOCKS ON THE MOVE-FTAI Aviation, Check Point, Sage Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street fell on Wednesday, with the tech-heavy Nasdaq leading declines after lackluster quarterly results from Tesla and Alphabet raised questions about the sustainability of the Big Tech and AI-led 2024 equity rally.

Thermo Fisher Scientific Inc reports results for the quarter ended in January - Earnings Summary Thermo Fisher Scientific Inc TMO.N reported quarterly adjusted earnings of $5.37​​ per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $5.15. The mean expectation of twenty two analysts for the quarter was for earnings of $5.12 per share.

US STOCKS-Nasdaq futures set to slide at open after Tesla, Alphabet disappoint For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Visa falls after missing revenue growth forecasts AT&T rises after beating subscriber-addition estimates Enphase Energy, Texas Instruments up after results Rivian falls; will face trial in Tesla trade secrets theft case Futures down: Dow 0.45%, S&P 500 0.90%, Nasdaq 1.39% Updated at 8:27 a.m.

REFILE-BUZZ-Thermo Fisher drops as raised profit forecast fails to impress Wall Street Corrects typo in company name in the headline ** Shares of medical equipment maker Thermo Fisher TMO.N down 3% at $535 premarket ** Co raises annual profit forecast to between $21.29 and $22.07 per share vs previous forecast of $21.14 to $22.02 ** Analysts were e

US STOCKS-Futures slide after Tesla, Alphabet earnings disappoint For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. AT&T rises after beating subscriber-addition estimates Enphase Energy, Texas Instruments up after results Visa falls after missing revenue growth forecasts Rivian falls; will face trial in Tesla trade secrets theft case Futures down: Dow 0.42%, S&P 500 0.69%, Nasdaq 1.04% Updated at 6:54 a.m.

Thermo Fisher lifts profit forecast as biotech demand shows signs of improvement July 24 (Reuters) - Thermo Fisher TMO.N on Wednesday raised its annual profit outlook and posted a better-than-expected second-quarter profit, banking on improved demand for its tools and services used in clinical trials. Contract drug manufacturers witnessed cut back on spending by their biotech clients in 2023 amid rising interest rates.

MORNING BID AMERICAS-High earnings bar, Harris polling bump A look at the day ahead in U.S. and global markets from Mike Dolan Wall St has suddenly become a tough crowd to please. Much like last week's cool market reception for decent earnings beats from streamer Netflix NFLX.O or chipmaker TSMC 2330.TW , Alphabet's GOOGL.O surprisingly muscular second quarter left its stock down 2% overnight - and even the artificial intelligence theme didn't wow the gallery.

BRIEF-Thermo Fisher Q2 Adjusted EPS USD 5.37 Vs. IBES Estimate USD 5.12 Jul 24 (Reuters) - Thermo Fisher Q2 EPS USD 4.04. Q2 adjusted EBIT USD 2,347 million vs. IBES estimate USD 2,304 million Q2 adjusted net income USD 2,057 million vs. IBES estimate USD 1,963 million Q2 revenue USD 10,541 million vs. IBES estimate USD 10,511 million outlook FY re

What to Watch in the Day Ahead - Wednesday, July 24 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Ford Motor is expected to post a drop in profit for the second quarter.

Thermo Fisher Scientific Inc expected to post earnings of $5.12 a share - Earnings Preview Thermo Fisher Scientific Inc TMO.N , TMO is expected to show a fall in quarterly revenue when it reports results on July 24 for the period ending June 30 2024 The Waltham Massachusetts-based company is expected to report a 1.7% decrease in revenue to $10.511 billion from $10.69 billion a year ago, according to the mean estimate from 19 analysts, based on LSEG data.

What to Watch in the Week Ahead and on Monday, July 22 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT ON MONDAY A meeting of the G20 finance ministers and central bank governors is scheduled to take place between July 22 and July 23, ahead of the G20 Brazil Summit 2024. The G20 finance ministe

Nvidia, Pfizer lead $80 mln funding for Israeli medical AI tech firm CytoReason JERUSALEM, July 17 (Reuters) - Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round. Nvidia NVDA.O , Pfizer PFE.N , Thermo Fisher TMO.N and venture capital investor OurCrowd participated in the round, CytoReason said.

BRIEF-Thermo Fisher Scientific Declares Quarterly Dividend July 11 (Reuters) - Thermo Fisher Scientific Inc TMO.N : THERMO FISHER SCIENTIFIC INC - AUTHORIZED A QUARTERLY CASH DIVIDEND OF $0.39 PER COMMON SHARE Source text for Eikon: ID:nBw5nbtna Further company coverage: TMO.N

BRIEF-Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology July 11 (Reuters) - Thermo Fisher Scientific Inc TMO.N : THERMO FISHER SCIENTIFIC TO HELP ADVANCE MYELOID CANCER CLINICAL RESEARCH AND TREATMENT UTILIZING NEXT GENERATION SEQUENCING TECHNOLOGY THERMO FISHER S

Deals of the day-Mergers and acquisitions Adds Petrobras, Envestnet, Metro Bank; Updates Eli Lilly, Masimo July 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1 945 GMT on Monday: * * Brazilian logistics firm Transpetro, a unit of state-run oil firm Petrobras PETR4.SA , said it has launched a procurement notice to commission four new coastal vessels, which it hopes will help revive the nation's shipbuilding sector.

Deals of the day-Mergers and acquisitions Adds: Masimo, Devon Energy, Vista Outdoor, Eli Lilly, Thermo Fisher Scientific's Updates: Paramount Global, Carlsberg, Grifols July 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday: ** Masimo MASI.O said a potential partner is prepared to offer $850 million to $950 million for its consumer business.

BRIEF-Olink Announces Receipt Of CMA Clearance For Proposed Acquisition By Thermo Fisher July 8 (Reuters) - Olink Holding AB (publ) OLK.O : OLINK ANNOUNCES RECEIPT OF CMA CLEARANCE FOR PROPOSED ACQUISITION BY THERMO FISHER Source text for Eikon: ID:nGNXZwSkq Further company coverage: OLK.O

UK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink deal July 8 (Reuters) - UK's competition regulator said on Monday it has cleared U.S. medical equipment maker Thermo Fisher Scientific's TMO.N $3.1 billion deal to buy Swedish biotech firm Olink Holding AB OLK.O . Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Sh